LinkedIn facebook twitter youtube
News archive
Recent news

Myeloma Patients Europe (MPE) held a webinar yesterday on myeloma and AL amyloidosis treatment update given by Dr Inger Nijhof, Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

This webinar is part of the webinars series planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the coronavirus infection.

Find below the recording of this webinar or watch it on our YouTube Channel:



Check below the list of webinars included in the MPE AGM 2020 webinar series and register now:

Topic Speaker Date and time Link to register
Webinar on reimbursement and Health Technology Assessment (HTA) Neil Bertelsen, Steering Committee member at Health Technology Assessment International (HTAi) Wednesday 18 March (18:00 – 19:00 CET)
Webinar on big data in haematology, the Harmony example Ana Rodríguez, Institute of Cancer Molecular and Biology (USAL-CSIC), Salamanca, Spain Thursday 2 April
(18:00 – 19:00 CET)
Webinar on Minimal Residual Disease (MRD) in myeloma and related diseases Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) member at the European Medicine Agency (EMA) Monday 20 April
(18:00 – 19:00 CET)
Webinar on personalised medicines in myeloma and AL amyloidosis Dr Francesca Bonello, Università degli Studi di Torino Monday 6 May
(18:00 – 19:00 CET)
Webinar on how to develop patient materials Alice Baron, Information Manager at Myeloma UK (MUK) 30 June
(18:00 – 19:00 CET)


Recent news

» Myeloma diagnosis can take over 5 months and require more than 4 medical consultations with more than 3 different specialists

» The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myeloma

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy